Zhongbao Yue

456 total citations
15 papers, 385 citations indexed

About

Zhongbao Yue is a scholar working on Molecular Biology, Geriatrics and Gerontology and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Zhongbao Yue has authored 15 papers receiving a total of 385 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 4 papers in Geriatrics and Gerontology and 3 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Zhongbao Yue's work include Sirtuins and Resveratrol in Medicine (4 papers), Mitochondrial Function and Pathology (3 papers) and RNA regulation and disease (2 papers). Zhongbao Yue is often cited by papers focused on Sirtuins and Resveratrol in Medicine (4 papers), Mitochondrial Function and Pathology (3 papers) and RNA regulation and disease (2 papers). Zhongbao Yue collaborates with scholars based in China and United States. Zhongbao Yue's co-authors include Peiqing Liu, Shaorui Chen, Zhuoming Li, Ping He, Yan-qing Ding, Jianmin Jiang, Boyu Zhang, Jia You, Jing Lü and Ying Gao and has published in prestigious journals such as Biochemical and Biophysical Research Communications, FEBS Letters and Journal of Dairy Science.

In The Last Decade

Zhongbao Yue

15 papers receiving 382 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Zhongbao Yue China	12	174	76	72	65	60	15	385
Xinhong Guo China	8	189 1.1×	44 0.6×	45 0.6×	68 1.0×	56 0.9×	14	400
Uddipak Rai India	7	161 0.9×	61 0.8×	37 0.5×	60 0.9×	60 1.0×	11	347
Yi‐Xiang Hong China	9	170 1.0×	52 0.7×	89 1.2×	35 0.5×	49 0.8×	13	333
Hussain Aldera Saudi Arabia	12	141 0.8×	35 0.5×	76 1.1×	65 1.0×	43 0.7×	20	372
Jieru Shen China	9	230 1.3×	52 0.7×	75 1.0×	50 0.8×	62 1.0×	11	410
Wenjiang Cao China	6	176 1.0×	44 0.6×	37 0.5×	59 0.9×	44 0.7×	7	351
Yong Yuan China	8	215 1.2×	47 0.6×	35 0.5×	66 1.0×	53 0.9×	15	435
Swati Prakash India	7	157 0.9×	60 0.8×	36 0.5×	61 0.9×	61 1.0×	14	344
Duen S. Chou Taiwan	9	156 0.9×	67 0.9×	73 1.0×	66 1.0×	28 0.5×	12	522
Xue-Fen Pang China	11	162 0.9×	31 0.4×	102 1.4×	69 1.1×	54 0.9×	13	468

Countries citing papers authored by Zhongbao Yue

Since Specialization

Citations

This map shows the geographic impact of Zhongbao Yue's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zhongbao Yue with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zhongbao Yue more than expected).

Fields of papers citing papers by Zhongbao Yue

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Zhongbao Yue. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zhongbao Yue. The network helps show where Zhongbao Yue may publish in the future.

Co-authorship network of co-authors of Zhongbao Yue

This figure shows the co-authorship network connecting the top 25 collaborators of Zhongbao Yue. A scholar is included among the top collaborators of Zhongbao Yue based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Zhongbao Yue. Zhongbao Yue is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

15 of 15 papers shown

Zhang, Zhong-Hao, Shaoling Huang, Zhongbao Yue, et al.. (2023). Whey protein powder with milk fat globule membrane attenuates Alzheimer's disease pathology in 3×Tg-AD mice by modulating neuroinflammation through the peroxisome proliferator-activated receptor γ signaling pathway. Journal of Dairy Science. 106(8). 5253–5265. 10 indexed citations

Ding, Yan-qing, Yuhong Zhang, Jing Lü, et al.. (2020). MicroRNA-214 contributes to Ang II-induced cardiac hypertrophy by targeting SIRT3 to provoke mitochondrial malfunction. Acta Pharmacologica Sinica. 42(9). 1422–1436. 35 indexed citations

Yu, Yue, et al.. (2019). Mn(OAc) ₃ ‐Mediated Regioselective C‐H Phosphonylation of Indolizines with H ‐Phosphonates. ChemistrySelect. 4(3). 1117–1120. 21 indexed citations

Zhang, Zhiyang, et al.. (2018). Rosmarinic Acid Ameliorates H ₂ O ₂ -Induced Oxidative Stress in L02 Cells Through MAPK and Nrf2 Pathways. Rejuvenation Research. 22(4). 289–298. 36 indexed citations

Yue, Zhongbao, Boyu Zhang, Min Yang, et al.. (2018). Calcium Signal Pathway is Involved in Prostaglandin E2 Induced Cardiac Fibrosis in Cardiac Fibroblasts. Journal of Pharmacy & Pharmaceutical Sciences. 21(1). 326–339. 5 indexed citations

He, Ping, Zhuoming Li, Zhongbao Yue, et al.. (2017). SIRT3 prevents angiotensin II-induced renal tubular epithelial-mesenchymal transition by ameliorating oxidative stress and mitochondrial dysfunction. Molecular and Cellular Endocrinology. 460. 1–13. 38 indexed citations

Chen, Yanfang, Shaorui Chen, Zhongbao Yue, et al.. (2016). Receptor-interacting protein 140 overexpression impairs cardiac mitochondrial function and accelerates the transition to heart failure in chronically infarcted rats. Translational research. 180. 91–102.e1. 3 indexed citations

Yue, Zhongbao, Jia You, Zhuoming Li, et al.. (2016). NMNAT3 is involved in the protective effect of SIRT3 in Ang II-induced cardiac hypertrophy. Experimental Cell Research. 347(2). 261–273. 47 indexed citations

Zhang, Xiaoying, Wei Li, Xiaojun Feng, et al.. (2016). STAT3 Suppression Is Involved in the Protective Effect of SIRT6 Against Cardiomyocyte Hypertrophy. Journal of Cardiovascular Pharmacology. 68(3). 204–214. 31 indexed citations

10.

Zhang, Boyu, Jianmin Jiang, Zhongbao Yue, et al.. (2016). Store-Operated Ca2+ Entry (SOCE) contributes to angiotensin II-induced cardiac fibrosis in cardiac fibroblasts. Journal of Pharmacological Sciences. 132(3). 171–180. 34 indexed citations

11.

Li, Zhuoming, Hui Gao, Zhongbao Yue, et al.. (2015). RIP140 triggers foam‐cell formation by repressing ABCA1/G1 expression and cholesterol efflux via liver X receptor. FEBS Letters. 589(4). 455–460. 11 indexed citations

12.

Li, Hong, Zhongbao Yue, Suowen Xu, et al.. (2014). Cryptotanshinone Attenuates Cardiac Fibrosis via Downregulation of COX-2, NOX-2, and NOX-4. Journal of Cardiovascular Pharmacology. 64(1). 28–37. 43 indexed citations

13.

Chen, Yanfang, Zhongbao Yue, Jian Zou, et al.. (2014). The p65 subunit of NF-κB involves in RIP140-mediated inflammatory and metabolic dysregulation in cardiomyocytes. Archives of Biochemistry and Biophysics. 554. 22–27. 18 indexed citations

14.

Liu, Min, Jiantao Ye, Si Gao, et al.. (2014). Salvianolic acid B protects cardiomyocytes from angiotensin II-induced hypertrophy via inhibition of PARP-1. Biochemical and Biophysical Research Communications. 444(3). 346–353. 26 indexed citations

15.

Chen, Xi, Siyu Zeng, Jian Zou, et al.. (2014). Rapamycin Attenuated Cardiac Hypertrophy Induced by Isoproterenol and Maintained Energy Homeostasis via Inhibiting NF-κB Activation. Mediators of Inflammation. 2014. 1–15. 27 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact